pirfenidone sandoz 801 mg
sandoz - københavn - pirfenidon - tablett, filmdrasjert - 801 mg
pirfenidone sandoz 267 mg
sandoz - københavn - pirfenidon - tablett, filmdrasjert - 267 mg
tolvaptan accord
accord healthcare s.l.u. - tolvaptan - upassende adh-syndrom - diuretika, - tolvaptan is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (siadh).
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).
tolvaptan teva 15 mg
teva b.v. - tolvaptan - tablett - 15 mg
tolvaptan teva b.v. 30 mg / 90 mg
teva b.v. - tolvaptan - tablett - 30 mg / 90 mg
tolvaptan teva b.v. 30 mg / 60 mg
teva b.v. - tolvaptan - tablett - 30 mg / 60 mg
tolvaptan teva b.v. 45 mg / 15 mg
teva b.v. - tolvaptan - tablett - 45 mg / 15 mg
zomarist
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
eucreas
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.